insights_auto
Zakaj je tečaj ALMKT padel 2,79%?
Podrobneje raziščichevron_right
ALMKT:EPA
Mauna Kea Technologies SA
0,087 €
arrow_downward
−2,79%(−0,0025) 1D
20. nov., 17:35:11 GMT +1 · EUR
search
Vsi simboli
| Simbol | Cena | Sprememba | Odstotna sprememba |
|---|
insights_autoGeneriranje najpomembnejših vpogledov za ALMKT …
Odpri
0,09 €
Visoka
0,09 €
Nizka
0,09 €
Tržna kapitalizacija
16,66 mio.
Povprečni promet
406,96 tis.
Promet
258,62 tis.
Razmerje med ceno delnice in čistim dobičkom
0,74
52-tedenski najvišji tečaj
0,23 €
52-tedenski najnižji tečaj
0,07 €
Čisti dobiček na delnico
0,12 €
Št. izdanih delnic
195,26 mio.
Št. zaposlenih
56
Odpri
0,09 €
Visoka
0,09 €
Nizka
0,09 €
Tržna kapitalizacija
16,66 mio.
Povprečni promet
406,96 tis.
Promet
258,62 tis.
Razmerje med ceno delnice in čistim dobičkom
0,74
52-tedenski najvišji tečaj
0,23 €
52-tedenski najnižji tečaj
0,07 €
Čisti dobiček na delnico
0,12 €
Št. izdanih delnic
195,26 mio.
Št. zaposlenih
56
Novice
Iz spletnih virov in novičarskih partnerjev
AP News
·
pred 1 dnevom
S&P 500 sinks 3.7% and Nasdaq composite goes negative for the year as tech sell-off worsens
The Motley Fool
·
pred 8 urami
The S&P 500 Is 14 for 14 After Midterm Elections. Here’s How I’d Invest Now.
Beinsure
·
pred 23 urami
Vanguard S&P 500 ETF: How investing in VOO could build a $1 mn portfolio
Benzinga
·
pred 1 uro
Dow Jones and S&P 500 Outlook: Top Stock Market Headlines and Data This Week
Profil
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Vizitka: Mauna Kea Technologies SA
Generalni direktorSacha Loiseau
Št. zaposlenih56
Ustanovljeno2000
Sedež-
SektorHealth Care
Panoga-
Spletno mestomaunakeatech.com